EC Healthcare Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Leslie Lu

Chief Executive Officer (CEO)

HK$20.6m

Compensación total

Porcentaje del salario del CEO	21.6%
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	1.8yrs
Promedio de permanencia en la Junta Directiva	8.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Leslie Lu en comparación con los beneficios de EC Healthcare?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2023	n/a	n/a	-HK$4m
Jun 30 2023	n/a	n/a	HK$33m
Mar 31 2023	HK$21m	HK$4m	HK$70m
Dec 31 2022	n/a	n/a	HK$93m
Sep 30 2022	n/a	n/a	HK$117m
Jun 30 2022	n/a	n/a	HK$157m
Mar 31 2022	HK$13m	HK$2m	HK$198m

Compensación vs. Mercado: La compensación total de Leslie($USD2.64M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD705.27K).

Compensación vs. Ingresos: La compensación de Leslie ha aumentado mientras la empresa no es rentable.

CEO

Leslie Lu (43 yo)

less than a year

Permanencia

HK$20,645,000

Compensación

Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Chi Fai Tang	Founder & Executive Chairman	8.5yrs	HK$1.12m	60.93% HK$ 120.2m
Lyn Wade Lu	Chief Executive Officer	less than a year	HK$20.65m	sin datos
Heung Wing Lee	CFO & Executive Director	4.8yrs	HK$12.02m	0.057% HK$ 113.3k
Wing Man Mak	Chief Operating Officer	3.4yrs	sin datos	sin datos
Tai Cheung Wong	Chief Operating Officer	1.8yrs	sin datos	sin datos
Kelly Tsang	Associate Director of Accounting	no data	sin datos	sin datos
Kin Keung Chan	Chief Public Affairs Officer & Chief Dental Officer	1.8yrs	sin datos	sin datos
Katy Ip	Sales Director	no data	sin datos	sin datos
Chun Pu Chu	Chief Business Officer	3.7yrs	sin datos	sin datos
Chun Yu Chan	Chief Talent Officer	1.8yrs	sin datos	sin datos
Julie Chow	Chief Proposition Officer of Healthcare	1.3yrs	sin datos	sin datos
Chun Pong Siu	Company Secretary	6.7yrs	sin datos	sin datos

1.8yrs

Permanencia media

44yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 1UM0 no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Chi Fai Tang	Founder & Executive Chairman	8.5yrs	HK$1.12m	60.93% HK$ 120.2m
Heung Wing Lee	CFO & Executive Director	4.3yrs	HK$12.02m	0.057% HK$ 113.3k
Ching Nam Ma	Independent Non-Executive Director	8.3yrs	HK$240.00k	0.025% HK$ 49.9k
Andrew Look	Independent Non-Executive Director	8.3yrs	HK$220.00k	sin datos
Kun Shing Luk	Non Executive Director	8.7yrs	HK$118.00k	0.24% HK$ 470.0k
Tsun Au	Independent Non-Executive Director	1.7yrs	HK$70.00k	sin datos

8.3yrs

Permanencia media

43.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 1UM0 se considera experimentada (8.2 años de antigüedad promedio).

EC Healthcare Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

EC Healthcare Announces Executive Changes

EC Healthcare, Annual General Meeting, Aug 23, 2023

Less than half of directors are independent

Chairman & Co-CEO recently bought €75k worth of stock

EC Healthcare Announces Executive Changes

Recent updates

Now 26% overvalued after recent price rise

Now 29% overvalued

Now 23% overvalued

EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million.

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

EC Healthcare Announces Executive Changes

Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023

Upcoming dividend of HK$0.042 per share at 2.6% yield

Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023

New major risk - Share price stability

Full year 2023 earnings released: EPS: HK$0.059 (vs HK$0.17 in FY 2022)

Full year 2023 earnings released: EPS: HK$0.059 (vs HK$0.17 in FY 2022)

EC Healthcare, Annual General Meeting, Aug 23, 2023

EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023

EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023

Upcoming dividend of HK$0.058 per share

First half 2023 earnings released

EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023

Less than half of directors are independent

EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022

EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022

Chairman & Co-CEO recently bought €75k worth of stock

EC Healthcare Announces Executive Changes

Upcoming dividend of HK$0.042 per share

EC Healthcare Approves Final Dividend for the Year Ended 31 March 2022, Payable on 20 September 2022

Full year 2022 earnings released: EPS: HK$0.17 (vs HK$0.19 in FY 2021)

EC Healthcare Proposes Final Dividend for the Year Ended 31 March 2022

Full year 2022 earnings released: EPS: HK$0.17 (vs HK$0.19 in FY 2021)

EC Healthcare, Annual General Meeting, Aug 23, 2022

EC Healthcare to Report Fiscal Year 2022 Final Results on Jun 23, 2022

EC Healthcare (SEHK:2138) entered into agreement to acquire 75% stake in Mobile Medical International Holdings Limited from certain existing shareholders for HKD 41.25 million.

Less than half of directors are independent

EC Healthcare Provides Sales Guidance for the Year Ended 31 March, 2022

EC Healthcare (SEHK:2138) completed the acquisition of Excellent Power Investments Limited from GenRx Holdings Limited.

Chairman & Co-CEO recently bought €60k worth of stock

EC Healthcare (SEHK:2138) entered into an agreement to acquire Excellent Power Investments Limited from GenRx Holdings Limited for HKD 68 million.

Chairman & Co-CEO recently bought €561k worth of stock

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of HK$0.10 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations

EC Healthcare (SEHK:2138) agreed to acquire a 55% stake in Bayley & Jackson Dental Surgeons Limited for approximately HKD 130 million.

Investor sentiment improved over the past week

COO & Executive Director Gabriel Lee has left the company

Upcoming dividend of HK$0.13 per share

Full year 2021 earnings released: EPS HK$0.19 (vs HK$0.29 in FY 2020)

COO & Executive Director recently sold €1.9m worth of stock

EC Healthcare (SEHK:2138) entered into an agreement to acquire 51% equity interests in King Equity, Eternal Harvest, HKVIC and Crown Leader from Dr. Tiong and Dr. Tan for HKD 66 million.

EC Healthcare has completed a Follow-on Equity Offering in the amount of HKD 231.1608 million.

Union Medical Healthcare Limited Provides Revenue Guidance for the Year Ended March 31, 2021

Union Medical Healthcare Limited (SEHK:2138) signed an agreement to acquire an additional 45% stake in Young Aesthetics Medical Limited from Arnold Jonathan Che Teng Young and Tan Ho Yin, Timothy for HKD 9.8 million.

New 90-day high: €0.84

COO & Executive Director recently sold €29k worth of stock

COO & Executive Director recently sold €67k worth of stock

New 90-day high: €0.66

Chairman & CEO recently bought €315k worth of stock

First half 2021 earnings released: EPS HK$0.044

Revenue misses expectations

Union Medical Healthcare Limited (SEHK:2138) entered into an agreement to acquire 97% stake in Pathlab Medical Laboratories Limited from Sunny Sea Global Limited.

New 90-day high: €0.62

First half 2021 earnings released: EPS HK$0.044

Union Medical Healthcare Limited (SEHK:2138) acquired additional 24% stake in New York Medical Group (Pain Center) Limited.

Union Medical Healthcare Limited to Report First Half, 2021 Results on Nov 26, 2020

New 90-day high: €0.55

New 90-day high - €0.50

New 90-day low - €0.44